Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations This Form 10-Q contains certain forward-looking statements including expectations of market... | May 5, 2023
Source: marketscreener.com
Page 21 - Development Expense News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Development Expense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Development Expense Today - Breaking & Trending Today
Cellectar Reports Financial Results for First Quarter 2023 and Provides a Corporate Update
FLORHAM PARK, N.J., May 04, 2023 -- Cellectar Biosciences, Inc. , a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for... | May 4, 2023
Source: marketscreener.com
The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and related notes, which appear elsewhere in this document, and with... | May 3, 2023
Source: marketscreener.com
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
Growth of VOXZOGO® Accelerated with Rapid Uptake in Japan and Brazil Resulting in Increased Full-year 2023 GuidanceFull-year 2023 Top-line and Bot...
Source: businessinsider.com
Biogen : Strong progress toward three potential launches in 2023; Company reports first quarter 2023 results and reaffirms full year 2023 guidance - Form 8-K
Strong progress toward three potential launches in 2023; Company reports first quarter 2023 results and reaffirms full year 2023 guidance First... | April 25, 2023
Source: marketscreener.com